Medical licensing and credentialing platform Medallion raised $43 million in a new funding round led by Acrew Capital. The round, which brings Medallion's total raise to $130 million, included ...

ArteraAI Prostate uses digital pathology images from a patient’s biopsy to predict potential long-term outcomes of their prostate cancer.

The companies will develop AI models trained on real-world data to help identify and diagnose patients with paroxysmal nocturnal hemoglobinuria.